Human MYO18A (Putative Tgfb1-Induced Anti-Apoptotic Factor 1) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-03039P
SDS-PAGE analysis of Human MYO18A (Putative Tgfb1-Induced Anti-Apoptotic Factor 1) - Recombinant Protein, CAT# BLT-03039P, showing >90% purity under 15% SDS-PAGE (Reduced)
Human MYO18A (Putative Tgfb1-Induced Anti-Apoptotic Factor 1) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-03039P
Regular price
$59500
$595.00
Sale price$54500
$545.00Save $50
/
Quantity Pricing
| Pack Size | Price (USD) |
|---|---|
| 500 µg | $1,375 |
| 1 mg | $2,245 |
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
| Product Name | Recombinant Human Putative TGFB1-induced anti-apoptotic factor 1 (TIAF1/MYO18A) Protein |
| Product Overview | This recombinant human Putative TGFB1-induced anti-apoptotic factor 1 (TIAF1/MYO18A) protein includes amino acids 1-115aa of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
| Target Uniprot Id | O95411 |
| Recommended Name | Putative TGFB1-induced anti-apoptotic factor 1 |
| Gene Name | MYO18A |
| Synonyms | TGFB1-induced anti-apoptotic factor 1, MAJN, SPR210 |
| Species | Human |
| Predicted Molecular Mass | 16.6 kDa |
| Expression System | E.coli |
| Expression Range | 1-115aa |
| Tag | N-6His |
| Purity | >90% |
| Formulation | Lyophilized |
| Buffer | Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
| Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
| Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
| Applications | Positive Control; Immunogen; SDS-PAGE; WB |
| Research Area | Cell Biology |
| Target Function | Inhibits the cytotoxic effects of TNF-alpha and overexpressed TNF receptor adapters TRADD, FADD, and RIPK1. Involved in TGF-beta1 inhibition of IkappaB-alpha expression and suppression of TNF-mediated IkappaB-alpha degradation. |
| Subcellular Location | Nucleus. |
| Tissue Specificity | Not detectable in normal kidney and liver. Up-regulated in chronic and acute allograft rejection: expressed in the inflammatory infiltrate and in tubular epithelial cells. |
